How can resources and support be directed to these regions to strengthen surveillance, prevention, and treatment efforts for Pseudomonas aeruginosa and other antibiotic-resistant infections?

... infection with pseudomonas aeruginosa in neurosurgery. Lancet, 1965, 2:365–368.Ayliffe, G. A. J., Lowbury, E. J. L., Hamilton, J. G., Small, J. M., Asheshov ... Dec 5, 2013 ... Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection. Benjamin J. Staudinger. aeruginosa eradication rate of 40% (95% CI 34–45%; p<0.00001), with no significant heterogeneity (I2=0%). Combined systemic and inhaled antibiotic treatment was ... Mar 22, 2024 ... FDA has completed their review of the rationale document titled, “Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa” (MR15, ... In this paper, we rigorously explore the role of two major bacterial adhesins, type IV pili (Tfp) and flagella, in bacterial adherence to distinct host ... Jul 1, 2022 ... What is Pseudomonas? Pseudomonas is a common type of bacteria usually found in soil and water. It rarely causes problems in people with healthy ... Jul 5, 2024 ... A series of epidemic clones emerged and expanded between 1850 and 2000, indicating recent selective pressures, possibly driven by industrialization, associated ... Objective. Investigate clonal dissemination of nosocomial multidrug-resistant Pseudomonas aeruginosa isolates within and between Brazilian intensive care ... Clinical Signs. P. aeruginosa infections typically are contracted from heavily infested surfaces such as tubing or water tubs, and virtually any animal can ... Most pseudomonads known to cause disease in humans are associated with opportunistic infections. These include P aeruginosa, P fluorescens, P putida, P cepacia, ...